
|Articles|December 15, 2022
How purpose-built tech can help pharmaceutical and life science companies streamline healthcare provider interactions
Author(s)PwC
In today’s hypercompetitive pharmaceutical and life sciences (PLS) industry, strategic partnerships are more critical than ever. While these third-party relationships can be full of risk and regulatory challenges, the right tech can help you navigate the complexities of compliance.
Trending on PharmExec
1
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
2
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
3
Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta
4
How Nuvation Bio Manages its Ongoing Clinical Trials
5